vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Franklin BSP Realty Trust, Inc. (FBRT). Click either name above to swap in a different company.
Franklin BSP Realty Trust, Inc. is the larger business by last-quarter revenue ($81.1M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). Franklin BSP Realty Trust, Inc. runs the higher net margin — 22.7% vs -70.9%, a 93.6% gap on every dollar of revenue. On growth, Franklin BSP Realty Trust, Inc. posted the faster year-over-year revenue change (25.8% vs 8.1%). Over the past eight quarters, Franklin BSP Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Franklin BSP Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) focused on originating, investing in, and managing a diversified portfolio of commercial real estate debt assets, including first mortgage loans, mezzanine financing and other credit-related real estate products. It operates primarily in the U.S. market, targeting consistent risk-adjusted returns and stable income distributions for investors.
CTKB vs FBRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $81.1M |
| Net Profit | $-44.1M | $18.4M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 22.7% |
| Revenue YoY | 8.1% | 25.8% |
| Net Profit YoY | -557.1% | -39.1% |
| EPS (diluted) | — | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $81.1M | ||
| Q3 25 | $52.3M | $89.5M | ||
| Q2 25 | $45.6M | $49.3M | ||
| Q1 25 | $41.5M | $50.1M | ||
| Q4 24 | $57.5M | $64.5M | ||
| Q3 24 | $51.5M | $54.0M | ||
| Q2 24 | $46.6M | $50.9M | ||
| Q1 24 | $44.9M | $54.0M |
| Q4 25 | $-44.1M | $18.4M | ||
| Q3 25 | $-5.5M | $17.3M | ||
| Q2 25 | $-5.6M | $23.2M | ||
| Q1 25 | $-11.4M | $24.1M | ||
| Q4 24 | $9.6M | $30.2M | ||
| Q3 24 | $941.0K | $31.6M | ||
| Q2 24 | $-10.4M | $-2.2M | ||
| Q1 24 | $-6.2M | $35.9M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | — | ||
| Q2 25 | -23.3% | — | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | -8.2% | — | ||
| Q2 24 | -18.3% | — | ||
| Q1 24 | -23.9% | — |
| Q4 25 | -70.9% | 22.7% | ||
| Q3 25 | -10.5% | 19.3% | ||
| Q2 25 | -12.2% | 47.1% | ||
| Q1 25 | -27.5% | 48.0% | ||
| Q4 24 | 16.8% | 46.8% | ||
| Q3 24 | 1.8% | 58.5% | ||
| Q2 24 | -22.4% | -4.3% | ||
| Q1 24 | -13.8% | 66.6% |
| Q4 25 | — | $0.13 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | — | $0.30 | ||
| Q2 24 | — | $-0.11 | ||
| Q1 24 | — | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $1.4B |
| Total Assets | $461.5M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $167.3M | ||
| Q3 25 | $93.3M | $116.7M | ||
| Q2 25 | $75.5M | $414.1M | ||
| Q1 25 | $95.3M | $215.4M | ||
| Q4 24 | $98.7M | $184.4M | ||
| Q3 24 | $162.3M | $346.2M | ||
| Q2 24 | $177.9M | $94.8M | ||
| Q1 24 | $168.8M | $240.0M |
| Q4 25 | $341.7M | $1.4B | ||
| Q3 25 | $378.6M | $1.5B | ||
| Q2 25 | $377.6M | $1.5B | ||
| Q1 25 | $379.6M | $1.5B | ||
| Q4 24 | $395.7M | $1.5B | ||
| Q3 24 | $385.5M | $1.5B | ||
| Q2 24 | $389.1M | $1.5B | ||
| Q1 24 | $392.6M | $1.6B |
| Q4 25 | $461.5M | $6.1B | ||
| Q3 25 | $494.9M | $6.2B | ||
| Q2 25 | $493.3M | $5.6B | ||
| Q1 25 | $482.6M | $5.7B | ||
| Q4 24 | $499.5M | $6.0B | ||
| Q3 24 | $491.2M | $6.3B | ||
| Q2 24 | $483.7M | $6.3B | ||
| Q1 24 | $492.1M | $6.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $291.9M |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | 15.88× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $291.9M | ||
| Q3 25 | $-3.9M | $-148.1M | ||
| Q2 25 | $108.0K | $11.8M | ||
| Q1 25 | $-125.0K | $116.2M | ||
| Q4 24 | $2.0M | $57.2M | ||
| Q3 24 | $13.2M | $97.4M | ||
| Q2 24 | $6.2M | $1.9M | ||
| Q1 24 | $4.0M | $13.0M |
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | 15.88× | ||
| Q3 25 | — | -8.56× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 4.83× | ||
| Q4 24 | 0.21× | 1.90× | ||
| Q3 24 | 14.05× | 3.08× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FBRT
| New Point Holdings JVLLC | $77.3M | 95% |
| Other | $2.1M | 3% |
| Office Building | $1.7M | 2% |
